CliffBio
small molecule

DILTIAZEM HYDROCHLORIDE

DILTIAZEM HYDROCHLORIDE

Loss of exclusivity—loss of exclusivity
CompanyApotex →See this company's full patent-cliff portfolio

Drug detail

Brand nameDILTIAZEM HYDROCHLORIDE
Active ingredientDILTIAZEM HYDROCHLORIDE
Strength180MG
Dosage formCAPSULE, EXTENDED RELEASE
RouteORAL
ModalitySmall molecule
FDA approvalDecember 2000
Marketing statusRX

More from Apotex

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the loss of exclusivity; estimates are projections, not legal advice.